Target intelligence / Profile preview

ribosomal protein L13a pseudogene 12 (RPL13AP12)

Target: RPL13AP12
Molecular classification: Other (Pseudogene)

Overview

RPL13AP12 is a processed pseudogene related to the ribosomal protein L13a gene (RPL13A), found in the human genome. Pseudogenes like RPL13AP12 typically do not produce functional proteins and do not have known biological functions or direct roles in disease. There are no known drugs, biomarkers, or therapeutic mechanisms associated with this pseudogene, and it is not classified as a therapeutic target. RPL13AP12 is a gene fragment derived from ribosomal protein L13a, classified strictly as a pseudogene with no therapeutic, diagnostic, or functional significance.

Other names: RPL13A_3_312RPL13AP12

Beyond the preview

Go deeper on ribosomal protein L13a pseudogene 12 (RPL13AP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L13a pseudogene 12 (RPL13AP12).

Explore the full profile